Publications by authors named "Ramesh Balusu"

Claim this Profile
A
A phase 1b study on the safety of Wharton's jelly mesenchymal stromal cells in the treatment of acute graft-versus-host disease.
William Wesson, Jianzheng Wu, Milind Phadnis, Scott Weir, Tyce Bruns, Ramesh Balusu

Cytotherapy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in stem cell and cellular therapeutics from the 9th Midwest Conference on Cell Therapy and Regenerative Medicine.
Ramesh Balusu, Rupal Soder, Nathaniel Dudley, Joseph P McGuirk, Sunil Abhyankar

Mol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splice-modulating strategies targeting the insulin receptor: A novel therapeutic pathway in osteosarcoma.
Divya R Singh, Rajvir Singh, Ramesh Balusu, Kishore B Challagundla

Mol Ther Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.
Anup S Pathania, Haritha Chava, Ramesh Balusu, Anil K Pasupulati, Don W Coulter

Mol Ther Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells.
Warren Fiskus, Rekha Rao, Ramesh Balusu, Siddhartha Ganguly, Jianguo Tao

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Joe S Al-Ramahi, Moazzam Shahzad, Kevin Li, Shaun DeJarnette, Sibgha Gull Chaudhary, Ramesh Balusu

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.
Moazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, Ali Hassan Mushtaq, Iqra Anwar, Ramesh Balusu

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis.
Moazzam Shahzad, Ezza Tariq, Sibgha Gull Chaudhary, Iqra Anwar, Qamar Iqbal, Ramesh Balusu

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis.
Razwana Khanam, Moazzam Shahzad, Sibgha Gull Chaudhary, Fatima Ali, Zunairah Shah, Ramesh Balusu

Leuk Lymphoma· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.
Konjeti R Sekhar, David N Hanna, Sriram Cyr, Jordan J Baechle, Sudhakiranmayi Kuravi, Ramesh Balusu

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Muhammad Umair Mushtaq, Moazzam Shahzad, Amna Y Shah, Sibgha Gull Chaudhary, Muhammad U Zafar, Ramesh Balusu

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of NPM1-TYK2 fusion oncogene.
Sudhakiranmayi Kuravi, Riley W Baker, Muhammad Umair Mushtaq, Irfan Saadi, Tara L Lin, Ramesh Balusu

NPJ Precis Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Moazzam Shahzad, Raheel S Siddiqui, Iqra Anwar, Sibgha Gull Chaudhary, Tayyaba Ali, Ramesh Balusu

Transplant Cell Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Mary Luder, Nausheen Ahmed, Ramesh Balusu

Transplant Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of Gilteritinib on NPM1-ALK-Driven Anaplastic Large Cell Lymphoma Cells.
Sudhakiranmayi Kuravi, Janice Cheng, Gabrielle Fangman, Kishore Polireddy, Sophia McCormick, Ramesh Balusu

Mol Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-mediated Potentiation of Bortezomib-induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells.
Rekha Rao, Srilatha Nalluri, Warren Fiskus, Andrew Savoie, Kathleen M Buckley, Ramesh Balusu

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapy for EBV-Associated B-cell Neoplasms.
Siddhartha Ganguly, Sudhakiranmayi Kuravi, Satyanarayana Alleboina, Giridhar Mudduluru, Roy A Jensen, Ramesh Balusu

Mol Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silver carbene complexes: An emerging class of anticancer agents.
Shravankumar Kankala, Niranjan Thota, Fredrik Björkling, Myles K Taylor, Ravinder Vadde, Ramesh Balusu

Drug Dev Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel tetrazole analogue of resveratrol is a potent anticancer agent.
Shobanbabu Bommagani, Narsimha Reddy Penthala, Meenakshisundaram Balasubramaniam, Sudhakiranmayi Kuravi, Eloisi Caldas-Lopes, Ramesh Balusu

Bioorg Med Chem Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas.
Sudhakiranmayi Kuravi, Elizabeth Parrott, Giridhar Mudduluru, Janice Cheng, Siddhartha Ganguly, Ramesh Balusu

Blood Cancer J· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates.
Xiaorong Gu, Quteba Ebrahem, Reda Z Mahfouz, Metis Hasipek, Francis Enane, Ramesh Balusu

J Clin Invest· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When the good go bad: Mutant NPM1 in acute myeloid leukemia.
Preethi Kunchala, Sudhakiranmayi Kuravi, Roy Jensen, Joseph McGuirk, Ramesh Balusu

Blood Rev· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).
Narsimha Reddy Penthala, Amit Ketkar, Konjeti R Sekhar, Michael L Freeman, Robert L Eoff, Ramesh Balusu

Bioorg Med Chem· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.
Konjeti R Sekhar, Mouadh Benamar, Amudhan Venkateswaran, Soumya Sasi, Narsimha R Penthala, Ramesh Balusu

Int J Radiat Oncol Biol Phys· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.
Warren Fiskus, Rekha Rao, Ramesh Balusu, Siddhartha Ganguly, Jianguo Tao

Clin Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis